Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kevin P. Hill, M.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R00DA029115 (HILL, KEVIN P.) May 1, 2013 - Apr 30, 2017
    Nabilone for Cannabis Dependence: Imaging and Neuropsychological Performance
    Role: Principal Investigator
  2. K99DA029115 (HILL, KEVIN P.) Mar 1, 2011 - Feb 28, 2013
    Nabilone for Cannabis Dependence: Imaging and Neuropsychological Performance
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Burnett GM, Gorelick DA, Hill KP. Policy Ahead of the Science: Medical Cannabis Laws Versus Scientific Evidence. Psychiatr Clin North Am. 2022 09; 45(3):347-373. PMID: 36055728.
    Citations:    Fields:    Translation:HumansAnimals
  2. Henner RL, Keshavan MS, Hill KP. Review of potential psychedelic treatments for PTSD. J Neurol Sci. 2022 08 15; 439:120302. PMID: 35700643.
    Citations:    Fields:    
  3. Hazle MC, Saxon AJ, Hill KP. Buprenorphine in safety-sensitive positions. Am J Drug Alcohol Abuse. 2022 05 04; 48(3):255-259. PMID: 35030309.
    Citations:    Fields:    Translation:Humans
  4. Hill KP, Gold MS, Nemeroff CB, McDonald W, Grzenda A, Widge AS, Rodriguez C, Kraguljac NV, Krystal JH, Carpenter LL. Risks and Benefits of Cannabis and Cannabinoids in Psychiatry. Am J Psychiatry. 2022 Feb; 179(2):98-109. PMID: 34875873.
    Citations: 2     Fields:    Translation:HumansAnimals
  5. Wu A, Parris RS, Scarella TM, Tibbles CD, Torous J, Hill KP. What gets resident physicians stressed and how would they prefer to be supported? A best-worst scaling study. Postgrad Med J. 2022 Dec; 98(1166):930-935. PMID: 34810273.
    Citations:    Fields:    
  6. Wu A, Radhakrishnan V, Targan E, Scarella TM, Torous J, Hill KP. Self-Reported Preferences for Help-Seeking and Barriers to Using Mental Health Supports Among Internal Medicine Residents: Exploratory Use of an Econometric Best-Worst Scaling Framework for Gathering Physician Wellness Preferences. JMIR Med Educ. 2021 Oct 06; 7(4):e28623. PMID: 34612838; PMCID: PMC8529465.
  7. Hill KP, Abrams DI. A cannabis oracle? Delphi method not a substitute for randomized controlled trials of cannabinoids as therapeutics. J Cannabis Res. 2021 Jul 02; 3(1):23. PMID: 34215325.
    Citations: 2     
  8. Smetana GW, Tetrault JM, Hill KP, Burns RB. Should You Recommend Cannabinoids for This Patient With Painful Neuropathy? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Ann Intern Med. 2021 02; 174(2):237-246. PMID: 33556279.
    Citations:    Fields:    Translation:Humans
  9. Hazle MC, Hill KP, Westreich LM. Workplace Cannabis Policies: A Moving Target. Cannabis Cannabinoid Res. 2022 02; 7(1):16-23. PMID: 33998870; PMCID: PMC8864412.
    Citations: 1     Fields:    Translation:HumansAnimalsPHPublic Health
  10. Williams AR, Hill KP. Care of the Patient Using Cannabis. Ann Intern Med. 2020 11 03; 173(9):ITC65-ITC80. PMID: 33137270.
    Citations:    Fields:    Translation:Humans
  11. Williams AR, Hill KP, Rosenthal RN, Connery HS, Welsh JW. Commentary: Proposed Model State Cannabis Laws to Reduce Harms. Am J Addict. 2020 09; 29(5):426-427. PMID: 32902047.
    Citations:    Fields:    
  12. Hill KP. Cannabinoids and the Coronavirus. Cannabis Cannabinoid Res. 2020 Jun 01; 5(2):118-120. PMID: 32656343.
    Citations: 12     Fields:    
  13. Hill KP. Medical Cannabis. JAMA. 2020 02 11; 323(6):580. PMID: 32044944.
    Citations: 3     Fields:    Translation:Humans
  14. Levinsohn EA, Hill KP. Clinical uses of cannabis and cannabinoids in the United States. J Neurol Sci. 2020 Apr 15; 411:116717. PMID: 32044684.
    Citations: 8     Fields:    Translation:HumansAnimals
  15. Li H, Smith SM, Gruber S, Lukas SE, Silveri MM, Hill KP, Killgore WDS, Nickerson LD. Denoising scanner effects from multimodal MRI data using linked independent component analysis. Neuroimage. 2020 03; 208:116388. PMID: 31765802.
    Citations: 7     Fields:    Translation:Humans
  16. Joseph JW, Marshall KD, Reich BE, Boyle KL, Hill KP, Weiner SG, Derse AR. How Emergency Physicians Approach Refusal of Observation after Naloxone Resuscitation. J Emerg Med. 2019 Nov 18. PMID: 31753755.
    Citations: 1     Fields:    
  17. Bonn-Miller MO, Pollack CV, Casarett D, Dart R, ElSohly M, Good L, Guzmán M, Hanuš L, Hill KP, Huestis MA, Marsh E, Sisley S, Skinner N, Spahr J, Vandrey R, Viscusi E, Ware MA, Abrams D. Priority Considerations for Medicinal Cannabis-Related Research. Cannabis Cannabinoid Res. 2019; 4(3):139-157. PMID: 31579832; PMCID: PMC6757233.
    Citations: 7     Fields:    
  18. Gomis-Vicent E, Thoma V, Turner JJD, Hill KP, Pascual-Leone A. Review: Non-Invasive Brain Stimulation in Behavioral Addictions: Insights from Direct Comparisons With Substance Use Disorders. Am J Addict. 2019 11; 28(6):431-454. PMID: 31513324.
    Citations: 2     Fields:    Translation:Humans
  19. Hill KP. Medical Use of Cannabis in 2019. JAMA. 2019 Sep 10; 322(10):974-975. PMID: 31397842.
    Citations: 17     Fields:    
  20. Sager ZS, Buss MK, Hill KP, Driver JA, Skarf LM. Managing Opioid Use Disorder in the Setting of a Terminal Disease: Opportunities and Challenges. J Palliat Med. 2020 02; 23(2):296-299. PMID: 31295046.
    Citations: 1     Fields:    Translation:Humans
  21. Williams AR, Hill KP. Cannabis and the Current State of Treatment for Cannabis Use Disorder. Focus (Am Psychiatr Publ). 2019 Apr; 17(2):98-103. PMID: 31975964.
    Citations: 4     
  22. Hill KP, Palastro MD, George TP. Therapeutic cannabis use in 2018: where do we stand? Lancet Psychiatry. 2019 02; 6(2):88-89. PMID: 30686389.
    Citations: 2     Fields:    Translation:HumansAnimals
  23. Hill KP, George TP. Cannabis legalisation in Canada: a crucial trial balloon. Lancet Psychiatry. 2019 01; 6(1):5-6. PMID: 30579495.
    Citations: 5     Fields:    Translation:HumansAnimals
  24. Lucatch AM, Coles AS, Hill KP, George TP. Cannabis and Mood Disorders. Curr Addict Rep. 2018 Sep; 5(3):336-345. PMID: 30643708; PMCID: PMC6329464.
    Citations: 5     
  25. Hill KP, Saxon AJ. The Role of Cannabis Legalization in the Opioid Crisis. JAMA Intern Med. 2018 05 01; 178(5):679-680. PMID: 29610836.
    Citations: 5     Fields:    Translation:HumansAnimals
  26. George TP, Hill KP, Vaccarino FJ. Cannabis Legalization and Psychiatric Disorders: Caveat "Hemp-tor". Can J Psychiatry. 2018 07; 63(7):447-450. PMID: 29482358.
    Citations: 6     Fields:    Translation:Humans
  27. Hill KP, Palastro MD. Medical cannabis for the treatment of chronic pain and other disorders: misconceptions and facts. Pol Arch Intern Med. 2017 11 30; 127(11):785-789. PMID: 29067992.
    Citations: 2     Fields:    Translation:Humans
  28. Hill KP, Palastro MD, Gruber SA, Fitzmaurice GM, Greenfield SF, Lukas SE, Weiss RD. Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study. Am J Addict. 2017 Dec; 26(8):795-801. PMID: 28921814.
    Citations: 13     Fields:    Translation:Humans
  29. Martin-Joy JS, Malone JC, Cui XJ, Johansen PØ, Hill KP, Rahman MO, Waldinger RJ, Vaillant GE. Development of Adaptive Coping From Mid to Late Life: A 70-Year Longitudinal Study of Defense Maturity and Its Psychosocial Correlates. J Nerv Ment Dis. 2017 09; 205(9):685-691. PMID: 28682982.
    Citations: 4     Fields:    Translation:Humans
  30. Hill KP, Palastro MD, Johnson B, Ditre JW. Cannabis and Pain: A Clinical Review. Cannabis Cannabinoid Res. 2017; 2(1):96-104. PMID: 28861509; PMCID: PMC5549367.
    Citations: 59     Fields:    
  31. Hill KP. Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders. JAMA. 2017 03 14; 317(10):1070-1071. PMID: 28291877.
    Citations: 10     Fields:    Translation:HumansAnimals
  32. Hill KP. Recreational cannabis legalisation: details will determine mental health effects. Lancet Psychiatry. 2016 09; 3(9):798-9. PMID: 27374073.
    Citations: 1     Fields:    Translation:AnimalsPHPublic Health
  33. Hill KP, Weiss RD. Minimal Physical Health Risk Associated With Long-term Cannabis Use--But Buyer Beware. JAMA. 2016 Jun 07; 315(21):2338-9. PMID: 27272585.
    Citations: 6     Fields:    Translation:HumansAnimals
  34. Hill KP, Hurley-Welljams-Dorof WM. Low to moderate quality evidence demonstrates the potential benefits and adverse events of cannabinoids for certain medical indications. Evid Based Med. 2016 Feb; 21(1):17. PMID: 26490847.
    Citations: 1     Fields:    Translation:Humans
  35. DeVido J, Connery H, Hill KP. Sleep-disordered breathing in patients with opioid use disorders in long-term maintenance on buprenorphine-naloxone: A case series. J Opioid Manag. 2015 Jul-Aug; 11(4):363-6. PMID: 26312963.
    Citations: 4     Fields:    Translation:Humans
  36. Hill K. Medical marijuana does not increase adolescent marijuana use. Lancet Psychiatry. 2015 Jul; 2(7):572-3. PMID: 26303534.
    Citations: 1     Fields:    Translation:HumansAnimals
  37. Hill KP. Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review. JAMA. 2015 Jun 23-30; 313(24):2474-83. PMID: 26103031.
    Citations: 155     Fields:    Translation:Humans
  38. Griffin ML, Bennett HE, Fitzmaurice GM, Hill KP, Provost SE, Weiss RD. Health-related quality of life among prescription opioid-dependent patients: Results from a multi-site study. Am J Addict. 2015 Jun; 24(4):308-14. PMID: 25808055.
    Citations: 20     Fields:    Translation:Humans
  39. McHugh RK, Fitzmaurice GM, Carroll KM, Griffin ML, Hill KP, Wasan AD, Weiss RD. Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients. Drug Alcohol Depend. 2014 Dec 01; 145:121-6. PMID: 25454409.
    Citations: 41     Fields:    Translation:Humans
  40. Hill KP. Medical marijuana: more questions than answers. J Psychiatr Pract. 2014 Sep; 20(5):389-91. PMID: 25226202.
    Citations: 5     Fields:    Translation:Humans
  41. Nathan M, Sleeper LA, Ohye RG, Frommelt PC, Caldarone CA, Tweddell JS, Lu M, Pearson GD, Gaynor JW, Pizarro C, Williams IA, Colan SD, Dunbar-Masterson C, Gruber PJ, Hill K, Hirsch-Romano J, Jacobs JP, Kaltman JR, Kumar SR, Morales D, Bradley SM, Kanter K, Newburger JW. Technical performance score is associated with outcomes after the Norwood procedure. J Thorac Cardiovasc Surg. 2014 Nov; 148(5):2208-13, 2214.e1-6. PMID: 25037617; PMCID: PMC4253672.
    Citations: 8     Fields:    Translation:Humans
  42. Hill KP. After detoxification: levels of treatment for alcohol dependence. Am Fam Physician. 2013 Nov 01; 88(9):576. PMID: 24364631.
    Citations:    Fields:    Translation:Humans
  43. Hill KP, Toto LH, Lukas SE, Weiss RD, Trksak GH, Rodolico JM, Greenfield SF. Cognitive behavioral therapy and the nicotine transdermal patch for dual nicotine and cannabis dependence: a pilot study. Am J Addict. 2013 May-Jun; 22(3):233-8. PMID: 23617864.
    Citations: 21     Fields:    Translation:HumansCTClinical Trials
  44. Hill KP, Bennett HE, Griffin ML, Connery HS, Fitzmaurice GM, Subramaniam G, Woody GE, Weiss RD. Association of cannabis use with opioid outcomes among opioid-dependent youth. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):342-5. PMID: 23528523.
    Citations: 12     Fields:    Translation:HumansPHPublic Health
  45. Bracken BK, Rodolico J, Hill KP. Sex, age, and progression of drug use in adolescents admitted for substance use disorder treatment in the northeastern United States: comparison with a national survey. Subst Abus. 2013; 34(3):263-72. PMID: 23844957.
    Citations: 10     Fields:    Translation:Humans
  46. Farren CK, Hill KP, Weiss RD. Bipolar disorder and alcohol use disorder: a review. Curr Psychiatry Rep. 2012 Dec; 14(6):659-66. PMID: 22983943.
    Citations: 23     Fields:    Translation:Humans
  47. Hill KP, Rice LS, Connery HS, Weiss RD. Diagnosing and treating opioid dependence. J Fam Pract. 2012 Oct; 61(10):588-97. PMID: 23106060.
    Citations:    Fields:    Translation:Humans
  48. Miller SG, Campbell MJ, Barker PC, Hill KD. Isolated right subclavian artery arising from the right pulmonary artery via a right-sided ductus arteriosus with associated pulmonary steal phenomenon. Cardiol Young. 2012 Apr; 22(2):216-8. PMID: 22380847.
    Citations: 2     Fields:    Translation:Humans
  49. Ross JS, Madigan D, Hill KP, Egilman DS, Wang Y, Krumholz HM. Pooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for postmarket pharmaceutical safety surveillance. Arch Intern Med. 2009 Nov 23; 169(21):1976-85. PMID: 19933959; PMCID: PMC2830805.
    Citations: 20     Fields:    Translation:HumansPHPublic Health
  50. Santa Ana EJ, Rounsaville BJ, Frankforter TL, Nich C, Babuscio T, Poling J, Gonsai K, Hill KP, Carroll KM. D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation. Drug Alcohol Depend. 2009 Oct 01; 104(3):220-7. PMID: 19592176.
    Citations: 49     Fields:    Translation:Humans
  51. Hill KD, Eckhauser AW, Marney A, Brown NJ. Phosphodiesterase 5 inhibition improves beta-cell function in metabolic syndrome. Diabetes Care. 2009 May; 32(5):857-9. PMID: 19196886.
    Citations: 18     Fields:    Translation:HumansCells
  52. Hill KP, Ross JS, Egilman DS, Krumholz HM. The ADVANTAGE seeding trial: a review of internal documents. Ann Intern Med. 2008 Aug 19; 149(4):251-8. PMID: 18711155.
    Citations: 35     Fields:    Translation:Humans
  53. Ross JS, Hill KP, Egilman DS, Krumholz HM. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA. 2008 Apr 16; 299(15):1800-12. PMID: 18413874.
    Citations: 88     Fields:    
  54. Patkar AA, Mannelli P, Peindl K, Hill KP, Wu LT, Lee T, Kuhn C. Relationship of the serotonin transporter with prolactin response to meta-chlorophenylpiperazine in cocaine dependence. J Psychiatr Res. 2008 Oct; 42(14):1213-9. PMID: 18321529.
    Citations: 3     Fields:    Translation:HumansCells
  55. Hill KP, Hope O. Combination of sumatriptan and naproxen for migraine. JAMA. 2007 Sep 19; 298(11):1276; author reply 1276-7. PMID: 17878418.
    Citations:    Fields:    Translation:Humans
  56. Sofuoglu M, Yoo S, Hill KP, Mooney M. Self-administration of intravenous nicotine in male and female cigarette smokers. Neuropsychopharmacology. 2008 Mar; 33(4):715-20. PMID: 17534380.
    Citations: 36     Fields:    Translation:HumansCTClinical Trials
  57. Hill KP, Chang G. Brief screening instruments for risky drinking in the outpatient psychiatry clinic. Am J Addict. 2007 May-Jun; 16(3):222-6. PMID: 17612827.
    Citations:    Fields:    Translation:Humans
  58. Hill KP, Sofuoglu M. Biological treatments for amfetamine dependence : recent progress. CNS Drugs. 2007; 21(10):851-69. PMID: 17850173.
    Citations: 6     Fields:    Translation:HumansAnimals
  59. Mannelli P, Patkar AA, Peindl K, Tharwani H, Gopalakrishnan R, Hill KP, Berrettini WH. Polymorphism in the serotonin transporter gene and moderators of prolactin response to meta-chlorophenylpiperazine in African-American cocaine abusers and controls. Psychiatry Res. 2006 Nov 15; 144(2-3):99-108. PMID: 17000009.
    Citations: 8     Fields:    Translation:HumansCells
  60. Patkar AA, Mannelli P, Hill KP, Peindl K, Pae CU, Lee TH. Relationship of prolactin response to meta-chlorophenylpiperazine with severity of drug use in cocaine dependence. Hum Psychopharmacol. 2006 Aug; 21(6):367-75. PMID: 16915581.
    Citations: 2     Fields:    Translation:Humans
  61. Hill KP. Free lunch? Am J Psychiatry. 2006 Apr; 163(4):569-70. PMID: 16585426.
    Citations:    Fields:    Translation:Humans
  62. Patkar AA, Mannelli P, Peindl K, Hill KP, Gopalakrishnan R, Berrettini WH. Relationship of disinhibition and aggression to blunted prolactin response to meta-chlorophenylpiperazine in cocaine-dependent patients. Psychopharmacology (Berl). 2006 Mar; 185(1):123-32. PMID: 16418827.
    Citations: 10     Fields:    Translation:Humans
  63. Hill KP, Lukonis CJ, Korson MS, Weinstein C, Thall M, Schwartz JT. Neuropsychiatric illness in a patient with cobalamin G disease, an inherited disorder of vitamin B12 metabolism. Harv Rev Psychiatry. 2004 Mar-Apr; 12(2):116-22. PMID: 15204806.
    Citations:    Fields:    Translation:Humans
  64. Hill KP, Oberstar JV, Dunn ER. Zolpidem-induced delirium with mania in an elderly woman. Psychosomatics. 2004 Jan-Feb; 45(1):88-9. PMID: 14709766.
    Citations: 7     Fields:    Translation:Humans
  65. Patkar AA, Thornton CC, Mannelli P, Hill KP, Gottheil E, Vergare MJ, Weinstein SP. Comparison of pretreatment characteristics and treatment outcomes for alcohol-, cocaine-, and multisubstance-dependent patients. J Addict Dis. 2004; 23(1):93-109. PMID: 15077843.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  66. Patkar AA, Gottheil E, Berrettini WH, Hill KP, Thornton CC, Weinstein SP. Relationship between platelet serotonin uptake sites and measures of impulsivity, aggression, and craving among African-American cocaine abusers. Am J Addict. 2003 Oct-Dec; 12(5):432-47. PMID: 14660157.
    Citations: 7     Fields:    Translation:HumansCells
  67. Patkar AA, Berrettini WH, Lundy A, Murray HW, Hill KP, Vergare MJ, Weinstein SP. Seasonal variations in the binding of [3H]paroxetine to the platelet serotonin transporter sites in African-American cocaine-dependent patients and healthy volunteers. Hum Psychopharmacol. 2003 Mar; 18(2):103-11. PMID: 12590403.
    Citations: 2     Fields:    Translation:HumansCells
  68. Patkar AA, Gottheil E, Berrettini WH, Thornton CC, Hill KP, Weinstein SP. Relationship between platelet serotonin uptake sites and treatment outcome among African-American cocaine dependent individuals. J Addict Dis. 2003; 22(1):79-92. PMID: 12661981.
    Citations: 4     Fields:    Translation:HumansCells
  69. Patkar AA, Berrettini WH, Hoehe M, Hill KP, Gottheil E, Thornton CC, Weinstein SP. No association between polymorphisms in the serotonin transporter gene and susceptibility to cocaine dependence among African-American individuals. Psychiatr Genet. 2002 Sep; 12(3):161-4. PMID: 12218660.
    Citations: 5     Fields:    Translation:Humans
  70. Patkar AA, Thornton CC, Berrettini WH, Gottheil E, Weinstein SP, Hill KP. Predicting treatment-outcome in cocaine dependence from admission urine drug screen and peripheral serotonergic measures. J Subst Abuse Treat. 2002 Jul; 23(1):33-40. PMID: 12127466.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  71. Patkar AA, Hill KP, Sterling RC, Gottheil E, Berrettini WH, Weinstein SP. Serum prolactin and response to treatment among cocaine-dependent individuals. Addict Biol. 2002 Jan; 7(1):45-53. PMID: 11900622.
    Citations: 4     Fields:    Translation:Humans
  72. Patkar AA, Berrettini WH, Hoehe M, Hill KP, Sterling RC, Gottheil E, Weinstein SP. Serotonin transporter (5-HTT) gene polymorphisms and susceptibility to cocaine dependence among African-American individuals. Addict Biol. 2001 Sep; 6(4):337-345. PMID: 11900612.
    Citations: 13     Fields:    
  73. Patkar AA, Hill KP, Weinstein SP, Schwartz SL. ECT in the presence of brain tumor and increased intracranial pressure: evaluation and reduction of risk. J ECT. 2000 Jun; 16(2):189-97. PMID: 10868329.
    Citations: 5     Fields:    Translation:Humans
  74. McLaughlin JP, Hill KP, Jiang Q, Sebastian A, Archer S, Bidlack JM. Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity. J Pharmacol Exp Ther. 1999 Apr; 289(1):304-11. PMID: 10087018.
    Citations: 16     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Hill's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (309)
Co-Authors (41)
Similar People (59)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.